A study of treatment of multi-organ dysfunction with MSC-CM
- Conditions
- Multi-Organ DysfunctionD001342
- Registration Number
- JPRN-jRCT1051230180
- Lead Sponsor
- Sugawara Kou
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 5
1 Individuals who did not experience satisfactory treatment effects for multi-organ dysfunction with standard therapy.
2 Individuals who, due to concerns about side effects or other reasons, do not wish to undergo treatment with drugs commonly used in standard therapy, and whose physicians have deemed treatment with culture supernatant appropriate for multi-organ dysfunction.
The patient selection criteria are outlined below.
Inclusion Criteria
Patients meeting the following criteria will be included:
1 Individuals aged 18 years or older.
2 Individuals possessing normal capacity to consent.
3 Individuals who have been provided with an informed consent document regarding this treatment, received sufficient explanation, and provided written consent voluntarily.
4 Individuals for whom the attending physician has recognized the necessity of treatment.
Individuals meeting any of the following conditions will be excluded from the study:
1. Users of narcotics or stimulants.
2. Individuals deemed inappropriate by the attending physician.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method